{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:48:55Z","timestamp":1790754535744,"version":"4.1.0"},"reference-count":16,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Background: Various authors have validated scales to measure comorbidity. However, the prognosis capacity variation according to the comorbidity measurement index used needs to be determined in order to identify which is the best predictor. Aims: To quantify the differences between the Charlson (CCI), Elixhauser (ECI) and van Walraven (WCI) comorbidity indices as prognostic factors for in-hospital mortality and to identify the best comorbidity measure predictor. Methods: A retrospective observational study that included all hospitalizations of patients over 18 years of age, discharged between 2017 and 2021 in the hospital, using the Minimum Basic Data Set (MBDS). We calculated CCI, ECI, WCI according to ICD-10 coding algorithms. The correlation and concordance between the three indices were evaluated by Spearman\u2019s rho and Intraclass Correlation Coefficient (ICC), respectively. The logistic regression model for each index was built for predicting in-hospital mortality. Finally, we used the receiver operating characteristic (ROC) curve for comparing the performance of each index in predicting in-hospital mortality, and the Delong method was employed to test the statistical significance of differences. Results: We studied 79,425 admission episodes. The 54.29% were men. The median age was 72 years (interquartile range [IQR]: 56\u201380) and in-hospital mortality rate was 4.47%. The median of ECI was = 2 (IQR: 1\u20134), ICW was 4 (IQR: 0\u201312) and ICC was 1 (IQR: 0\u20133). The correlation was moderate: ECI vs. WCI rho = 0.645, p &lt; 0.001; ECI vs. CCI rho = 0.721, p &lt; 0.001; and CCI vs. WCI rho = 0.704, p &lt; 0.001; and the concordance was fair to good: ECI vs. WCI Intraclass Correlation Coefficient type A (ICCA) = 0.675 (CI 95% 0.665\u20130.684) p &lt; 0.001; ECI vs. CCI ICCA = 0.797 (CI 95% 0.780\u20130.812), p &lt; 0.001; and CCI vs. WCI ICCA = 0.731 (CI 95% 0.667\u20130.779), p &lt; 0.001. The multivariate regression analysis demonstrated that comorbidity increased the risk of in-hospital mortality, with differences depending on the comorbidity measurement scale: odds ratio [OR] = 2.10 (95% confidence interval [95% CI] 2.00\u20132.20) p &gt; |z| &lt; 0 using ECI; OR = 2.31 (CI 95% 2.21\u20132.41) p &gt; |z| &lt; 0 for WCI; and OR = 2.53 (CI 95% 2.40\u20132.67) p &gt; |z| &lt; 0 employing CCI. The area under the curve [AUC] = 0.714 (CI 95% 0.706\u20130.721) using as a predictor of in-hospital mortality CCI, AUC = 0.729 (CI 95% 0.721\u20130.737) for ECI and AUC = 0.750 (CI 95% 0.743\u20130.758) using WCI, with statistical significance (p &lt; 0.001). Conclusion: Comorbidity plays an important role as a predictor of in-hospital mortality, with differences depending on the measurement scale used, the van Walraven comorbidity index being the best predictor of in-hospital mortality.<\/jats:p>","DOI":"10.3390\/ijerph191811262","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T20:52:03Z","timestamp":1662583923000},"page":"11262","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparison of Three Comorbidity Measures for Predicting In-Hospital Death through a Clinical Administrative Nacional Database"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8812-8513","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Oterino-Moreira","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Hospital Universitario Fundaci\u00f3n Alcorc\u00f3n, 28922 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Lorenzo-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Quality and Patient Management, Hospital Universitario Fundaci\u00f3n Alcorc\u00f3n, 28922 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"L\u00f3pez-Delgado","sequence":"additional","affiliation":[{"name":"Department of Clinical Analysis, Hospital Cl\u00ednico San Carlos, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4505-2958","authenticated-orcid":false,"given":"Montserrat","family":"P\u00e9rez-Encinas","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hospital Universitario Fundaci\u00f3n Alcorc\u00f3n, 28922 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1370\/afm.983","article-title":"Defining Comorbidity: Implications for Understanding Health and Health Services","volume":"7","author":"Valderas","year":"2009","journal-title":"Ann. Fam Med."},{"key":"ref_2","unstructured":"Librero, J., Cuenca, C., and Peir\u00f3, S. (2002). Comorbilidad e \u00cdndice Charslon. Aplicaciones CMBD. Quaderns de Salut P\u00fablica y Administraci\u00f3 de Serveis de Salut, Escola Valenciana d\u2019 Estudis per a Salut."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity Measures for Use with Administrative Data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med. Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative Data","volume":"47","author":"Austin","year":"2009","journal-title":"Med. Care"},{"key":"ref_6","unstructured":"(2022, June 10). Royal Decree 69\/2015 of February 6, Which Regulates the Register of Specialized Health Care Activity. Madrid: BOE, No. 35, (10 February 2015). Available online: https:\/\/www.boe.es\/."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1159\/000520644","article-title":"Impact of Penicillin Allergy Label on Length of Stay and Mortality in Hospitalized Patients through a Clinical Administrative National Dataset","volume":"183","author":"Walter","year":"2022","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","article-title":"User\u2019s guide to correlation coefficients","volume":"18","author":"Akoglu","year":"2018","journal-title":"Turk. J. Emerg. Med."},{"key":"ref_10","unstructured":"Fleiss, J.L. (1986). The Design and Analysis of Clinical Experiments, Wiley."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tsai, K.Y., Hsieh, K.Y., Ou, S.Y., Chou, F.H.C., and Chou, Y.M. (2020). Comparison of Elixhauser and Charlson Methods for Discriminative Performance in Mortality Risk in Patients with Schizophrenic Disorders. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17072450"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1089\/pop.2011.0037","article-title":"Comparative Performance of Comorbidity Indices in Predicting Health Care-Related Behaviors and Outcomes among Medicaid Enrollees with Type 2 Diabetes","volume":"15","author":"Ou","year":"2012","journal-title":"Popul. Health Manag."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1007\/s11999-014-3686-7","article-title":"The Elixhauser Comorbidity Method Outperforms the Charlson Index in Predicting Inpatient Death After Orthopaedic Surgery","volume":"472","author":"Menendez","year":"2014","journal-title":"Clin. Orthop."},{"key":"ref_15","unstructured":"Oterino-Moreira, I., Sanz Marquez, S., Zhan Zhou, E., Martinez Simon, J.J., Morales Catalan, M.C., Lorenzo Martinez, S., and Perez Encinas, M. (2022, June 17). Incidence of Adverse Drug Reactions in COVID-19 Hospitalised Patients through the Minimum Basic Data Set. Ofil-Ilaphar. Available online: https:\/\/www.ilaphar.org\/wp-content\/uploads\/2021\/11\/ORG-Incidence-of-adverse-drug-reaction-in-COVID-19.pdf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0213-9111(98)76473-8","article-title":"Previenen las enfermedades cr\u00f3nicas la mortalidad intrahospitalaria? Paradojas y sesgos en la informaci\u00f3n sobre morbilidad hospitalaria","volume":"12","author":"Librero","year":"1998","journal-title":"Gac. Sanit."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/18\/11262\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:25:11Z","timestamp":1760142311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/18\/11262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":16,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["ijerph191811262"],"URL":"https:\/\/doi.org\/10.3390\/ijerph191811262","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]}}}